在性酸酶 (ALP) 中出现的潜在方法可激活的癌症治疗药物
1Laboratory of Chemical Biology and Medicinal Chemistry, Department of Chemistry, Indian Institute of Technology Roorkee Uttarakhand-247667 India venkatesh.v@cy.iitr.ac.in.
RSC medicinal chemistry
|April 26, 2024
概括
性酸酶 (ALP) 是一种在癌症中过度表达的关键酶. 最近的进展集中在ALP激活的治疗药物上,释放细胞毒剂和用于癌症诊断和治疗的成像信号.
科学领域:
- 生物化学和分子生物学
- 癌症研究 癌症研究
- 热门节目 热门节目 热门节目
背景情况:
- 酸酶 (ALP) 是一种重要的酶,在生物过程中起着重要作用.
- 癌细胞中ALP的过度表达使其成为癌症检测和治疗的有希望的生物标志物.
- 最近的研究 (2019年以后) 探索了ALP在晚期癌症治疗中的潜力.
研究的目的:
- 审查性酸酶基癌症治疗的最新进展.
- 突出酸盐锁定分子系统的应用,用于向癌症治疗.
- 讨论这些系统在药物输送和成像中的双重作用.
主要方法:
- 专注于酸盐锁定分子系统,包括,前药物和聚合诱导排放 (AIE) 基分子.
- 研究ALP触发的细胞毒剂释放机制.
- 在遇到癌细胞时检查光体的激活,用于成像.
主要成果:
- 酸盐锁定系统被癌细胞过度表达的ALP有效地化.
- 这种水解释放出强大的细胞毒剂来杀死癌细胞.
- 同时,启动或预先存在的光体被激活,使成像成为可能.
结论:
- 激活ALP的治疗药物代表了针对性癌症治疗的重大突破.
- 这些系统为癌症的同时治疗和成像提供了一种双重方法.
- 新型酸盐锁定分子系统的开发对未来的癌症治疗学有很大的前景.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K


